Ritonavir Pellets

(Product under development)
Ritonavir PelletsRitonavir, with trade name Norvir, is an antiretroviral drug from the protease inhibitor class used to treat HIV infection and AIDS.

Ritonavir is frequently prescribed with HAART, not for its antiviral action, but as it inhibits the same host enzyme that metabolizes other protease inhibitors.

This inhibition leads to higher plasma concentrations of these latter drugs, allowing the clinician to lower their dose and frequency and improving their clinical efficacy.

Available Form:
Ritonavir Pellets
Ritonavir Granules

Umang Pharmatech equipments used for production of Ritonavir Pellets:
Drug Layering, Fluid Bed Dryer, Fluid Bed Coater, Sifter & Blender, Extruder and Twin spheronizer.


Ritonavir Pellets
Systematic (IUPAC) Name
Ritonavir Pellets
Identifiers
Ritonavir Pellets
Chemical data
1,3-thiazol-5-ylmethyl
N-[(2S,3S,5S)-3-hydroxy-
5-[(2S)-3-methyl-2-{[methyl(
{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl})carbamoyl]amino}
butanamido]-1,6-diphenylhexan-2-yl]carbamate
CAS number : 155213-67-5
ATC code : J05AE03
PubChem : CID 392622
DrugBank : APRD00312
ChemSpider : 347980
UNII : O3J8G9O825
KEGG : D00427
ChEMBL : CHEMBL163
Formula : C37H48N6O5S2
Mol. mass : 720.946 g/mol


* All transactions are carried out in conformity with patent laws applicable in the user country. Active pharmaceutical ingredients or formulations thereof will not be supplied in countries where the same is under patent protection except as and if permitted under law of the country for research and development purposes only.
Extruder Spheronizer Email Us Umang Pharmatech
TESTIMONIAL